Revenue
0 USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Annual consolidated revenue for 2025: about USD 7.528M, using the latest reported figures. The previous period, 2024, was about USD 3.344M.
0 USD
2026 Q2 · USD
14000000 USD
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-02.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 3.34 million
–
Current period
USD 7.53 million
–
7528000 − 3344000 = 4184000 USD
3344000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source7528000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 10.57 million
–
Current period
−USD 7.71 million
–
-7707000 − -10567000 = 2860000 USD
-10567000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-7707000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 12.94 million
–
Current period
−USD 6.63 million
–
-6625000 − -12940000 = 6315000 USD
-12940000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-6625000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 0
–
Current period
USD 11,000
–
11000 − -0 = 11000 USD
-0 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source11000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | 0 | 25264000 Derived | -25264000 | -2095000 Derived | -23169000 | -26066000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 73000 | 22270000 Derived | -22197000 | -72000 Derived | -22125000 | -17778000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 3344000 | 18076000 Derived | -14732000 | -4165000 Derived | -10567000 | -12940000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 7528000 | 16762000 Derived | -9234000 | -1527000 Derived | -7707000 | -6636000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Revenue | 0 |
|
| 2023 | Revenue | 73000 |
|
| 2024 | Revenue | 3344000 |
|
| 2025 | Revenue | 7528000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 4,480.8% |
|
| 2025 | Year over year | 125.1% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Operating margin | Not reported |
|
| 2023 | Operating margin | -30,406.8% |
|
| 2024 | Operating margin | -440.6% |
|
| 2025 | Operating margin | -122.7% |
|
| 2022 | Net margin | Not reported |
|
| 2023 | Net margin | -30,308.2% |
|
| 2024 | Net margin | -316% |
|
| 2025 | Net margin | -102.4% |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | -24,353.4% |
|
| 2024 | Free cash flow margin | -387% |
|
| 2025 | Free cash flow margin | -88.2% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Operating cash flow | -25774000 |
|
| 2023 | Operating cash flow | -17691000 |
|
| 2024 | Operating cash flow | -12940000 |
|
| 2025 | Operating cash flow | -6625000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Free cash flow | -26066000 |
|
| 2023 | Free cash flow | -17778000 |
|
| 2024 | Free cash flow | -12940000 |
|
| 2025 | Free cash flow | -6636000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2023 | Liabilities / assets | 136.7% |
|
| 2024 | Liabilities / assets | 113.2% |
|
| 2025 | Liabilities / assets | 40% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2023 | Current assets / current liabilities | 1.18× |
|
| 2024 | Current assets / current liabilities | 2.01× |
|
| 2025 | Current assets / current liabilities | 5.85× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | −USD 23.17 million Exact valueExact value: -23169000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 25.77 million Exact valueExact value: -25774000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 292,000 Exact valueExact value: 292000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 26.07 million Calculation and evidence-25774000 − 292000 USD Exact free cash flow: -26066000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 22.13 million Exact valueExact value: -22125000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.69 million Exact valueExact value: -17691000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 87,000 Exact valueExact value: 87000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.78 million Calculation and evidence-17691000 − 87000 USD Exact free cash flow: -17778000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 10.57 million Exact valueExact value: -10567000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.94 million Exact valueExact value: -12940000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: -0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.94 million Calculation and evidence-12940000 − -0 USD Exact free cash flow: -12940000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 7.71 million Exact valueExact value: -7707000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.63 million Exact valueExact value: -6625000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 11,000 Exact valueExact value: 11000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.64 million Calculation and evidence-6625000 − 11000 USD Exact free cash flow: -6636000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
249 filings · 2,217 latest values · 2,217 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001828253, 1828253, EVAX, edgar:1828253
Also known as Evaxion A/S, Evaxion Biotech A/S